1. US Myeloma Innovations Research Collaborative (USMIRC) Kansas City Kansas USA
2. Department of Hematology‐Oncology, Cleveland Clinic Taussig Cancer Center Cleveland Ohio USA
3. Division of Hematologic Malignancies and Cellular Therapeutics University of Kansas Medical Center Westwood Kansas USA
4. Department of Hematology‐Oncology Medical College of South Carolina Charleston South Carolina USA
5. Department of Biostatistics and Quantitative Health Sciences Cleveland Clinic Cleveland Ohio USA